2-(3-Methyl-3H-diazirin-3-yl)ethanamine

Catalog No. :
ACTCUD620
CAS No. :
36902-22-4
Molecular Formula :
C4H9N3
Molecular Weight :
99.14

IUPAC Name:2-(3-methyl-3H-diazirin-3-yl)ethan-1-amine

2-(3-Methyl-3H-diazirin-3-yl)ethanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg97%$78.00Login to see priceIn stockInquiry
50mg97%$131.00Login to see priceIn stockInquiry
100mg97%$223.00Login to see priceIn stockInquiry
250mg97%$440.00Login to see priceIn stockInquiry
1g97%$1320.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3-Methyl-3H-diazirin-3-yl)ethanamine
IUPAC Name2-(3-methyl-3H-diazirin-3-yl)ethan-1-amine
MDL No.MFCD19204990
Molecular FormulaC4H9N3
Molecular Weight99.14
SMILESCC1(CCN)N=N1
InChI KeyWXVCSPSTLPNOAA-UHFFFAOYSA-N
Synonym3-Methyl-3H-diazirine-3-ethanamine;2-(3-methyl-3H-diazirin-3-yl)ethanamine;2-(3-Methyl-3H-diazirin-3-yl)ethan-1-amine;2-(3-methyl-3H-diazirin-3-yl)ethylamine;3H-Diazirine-3-ethanamine, 3-methyl-;Me-Diazirine-Amine;2-(3-methyldiazirin-3-yl)ethanamine
CAS No.36902-22-4
PubChem CID55281506

Safety Data

Pictogram
CorrosiveFlammableHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H226-H302-H314-H335
Precautionary Statement(s)
P210-P260-P264-P270-P271-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P370+P378-P403+P233-P403+P235-P405-P501

Synthetic Route by SureRoute

1. ACTCUD620 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTCUD620 route product structure diagram
    ACTCUD62036902-22-4 In Stock
Inquiry

2. ACTCUD620 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTCUD620 route product structure diagram
    ACTCUD62036902-22-4 In Stock
Inquiry

Comments (0)